MARK PRIOLA: Open Payments
NPI 1407161235 · PRESCOTT VALLEY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 31 payments from 14 companies in 2025. Trend: 2023 $232 · 2024 $425 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $177 |
| Dexcom, Inc. | 2 | $105 |
| Exact Sciences Corporation | 4 | $87 |
| Novo Nordisk Inc | 3 | $87 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $70 |
| Astellas Pharma US Inc | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| Lilly USA, LLC | 2 | $30 |
| Renalytix AI, Inc. | 1 | $22 |
Products named: AIRSUPRA, Dexcom G6 Transmitter, TRELEGY ELLIPTA, CAPLYTA, The Cologuard Plus Collection Kit, Ozempic, Veozah, Wegovy.
Industry payments across AZ — which companies pay providers there.
